25
Participants
Start Date
October 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Quarfloxin
IV Quarfloxin 240 mg/m2 daily x5 days every 21 days
Ocala
Texas Oncology, Dallas
Tyler Cancer Center, Tyler
UT Health Science Center, San Antonio
Rocky Mountain Cancer Centers, Denver
Virginia Mason Medical Center, Seattle
Northwest Cancer Specialists, Vancouver
Birmingham Hematology and Oncology, Birmingham
Front Range Cancer Specialists, Fort Collins
Southern New Mexico Cancer Center, Las Cruces
Texas Oncology, Amarillo
El Paso Cancer Treatment Center, El Paso
Cancer Care Centers of South Texas, Kerrville
Lead Sponsor
Cylene Pharmaceuticals
INDUSTRY